3M's $7.35 Billion AFFF Deal Sets the Mass-Tort Benchmark
On November 3, 2026, 3M disclosed via SEC 8-K a $7.35 billion nominal settlement, $5.8 billion in present value, resolving roughly 99 percent of personal-injury PFAS claims tied to AFFF firefighting foam. The deal covers an estimated 115,000 to 120,000 plaintiffs inside and outside MDL No. 2873 in the District of South Carolina, with no admission of liability.
Payments start at $50 million this year and stretch through 2034. For firms still screening AFFF intake, that schedule lands near $61,000 to $64,000 average per plaintiff before fees and liens, though individual allocations track injury tier and exposure duration under the settlement's points matrix. Counsel with pending non-MDL filings should confirm opt-in deadlines now.
The remaining one percent of holdout claims will litigate alone against a defendant with no further incentive to negotiate quickly. DuPont still carries roughly 13,700 pending PFAS cases, and plaintiff firms are already citing the 3M figure as a valuation anchor in those talks, while lien teams face a multi-year payout schedule that complicates the usual lump-sum lien close-out.
The 3M figure now functions as the de facto PFAS claim-valuation ceiling for every defendant still negotiating.
California's SB 623 Forces a Lien-Billing Audit Before January 1
California's SB 623, codified at Civil Code section 3333.9 and effective January 1, 2027, caps recoverable past medical expenses in rideshare personal-injury claims at the 70th percentile of FAIR Health billed-charge data. The statute also opens broad discovery into the financial relationships between plaintiff counsel and lien-based treatment clinics, extending past the 2018 Pebley line on billed-versus-paid damages.
Firms running TNC dockets have roughly eight weeks to audit lien-intake questionnaires, vendor contracts, and client disclosure language before the cap applies. Lien clinics pricing treatment above the 70th-percentile benchmark risk having the excess stripped at trial, and the new discovery exposure means referral arrangements counsel assumed were insulated may now reach defense depositions.
Holland and Knight and Advocate Magazine both flagged SB 623 as the most consequential California lien-billing reform since Pebley. For medical providers listed in lien directories, the practical issue is pricing transparency: clinics that can document FAIR Health-aligned rates ahead of the deadline will be easier for counsel to defend on cross-examination and easier to recommend inside compliance-focused referral networks.
Any firm still billing TNC liens above the FAIR Health 70th percentile after January 1 is handing the defense a built-in discovery motion.
Birkel v. Gheith's $30 Million Punitive Verdict Raises Pain-Clinic Exposure
A St. Louis County jury's August 25, 2026 verdict in Birkel v. Gheith, re-surfaced by Missouri Lawyers Media on November 4, awarded Patricia Birkel $37.04 million: $7.04 million compensatory plus $30 million combined punitive damages against Dr. Gheith and Interventional Pain Institute. The theory centered on failure to order a timely thoracic MRI despite worsening neurological symptoms, allowing a spinal mass to cause irreversible tissue damage and partial paralysis.
The punitive split, $20 million against the physician individually and $10 million against the clinic entity, shows juries are willing to punish failure-to-refer patterns separately from the underlying diagnostic miss when documentation shows repeated patient complaints met administrative delay instead of escalation. Defense has filed a motion to stay judgment, so collection remains unresolved.
For malpractice counsel building pain-management claims, Birkel offers a working template: pair the delayed-diagnosis compensatory theory with a systemic-communication count against the clinic itself rather than the physician alone. That structure appears to be what pushed the punitive multiple past four times compensatory, a ratio worth tracking once appellate due-process challenges arrive.
A $30 million punitive award against a pain clinic, not just its physician, reframes failure-to-refer exposure as an entity-level risk.
NHTSA's Recall Week Opens Four New Auto-PI Intake Channels
NHTSA's November 2 to 6 recall slate gives auto-PI intake teams concrete defect theories heading into year-end. Hyundai's recall of 37,901 Kona Electric and Veloster N vehicles addresses an airbag control unit software fault that can deactivate airbags and seat-belt pretensioners; Hyundai has logged 331 alleged incidents as of October 22 with no confirmed crash injury yet.
Ford's recall covers roughly 30,123 F-150 and Super Duty trucks for a tailgate cable failure creating pedestrian and bystander exposure, while Lincoln's 11,623-unit Nautilus and Corsair Hybrid recall addresses transmission-module corrosion that can drop the vehicle into neutral unexpectedly. Toyota's Sienna Hybrid recall targets a seat-back latch defect across model years 2022 through 2026.
On the commercial side, Kenworth and Peterbilt recalled 26,729 units for fuel hose leak risk, and a separate school bus body-joint defect recall covers 13,593 units. Firms with active trucking dockets should cross-reference VIN ranges now; airbag non-deployment and seat-restraint failure claims historically produce the highest-value awards in this category.
The Hyundai incident count sits at 331 with zero confirmed injuries, meaning the real caseload here is still forming rather than filed.
AI Crosses From Pilot to Production Inside PI Firm Operations
LawPro.ai's Future of Legal Tech 2026 report, surveying more than 300 PI firms and co-released with Morgan and Morgan, found more than half now use AI operationally rather than experimentally, concentrated in intake triage, medical record chronology, and demand-package drafting. That matches what firm operators are describing in vendor calls this quarter.
Thomson Reuters' partnership with Supio, whose $25 million Series A was led by Sapphire Ventures, folds AI-driven medical chronology and lien tracking directly into CoCounsel Legal. That integration targets the exact bottleneck, record review before demand drafting, that determines how fast a lien resolves and how accurately a provider's bills get summarized for adjusters.
For medical providers in lien-based referral networks, the shift matters beyond vendor news. If AI triage tools are scoring treatment records for completeness and billing clarity before a case reaches a demand package, providers whose documentation is already structured and FAIR Health-aligned will surface faster in attorney workflows. Providers still faxing records on request are the ones AI adoption will quietly route around.
More than half of surveyed PI firms now run AI in daily casework, which means provider documentation quality is becoming a referral-ranking factor whether providers know it or not.
What the Bar Should Watch Before Year-End
Three deadlines converge on firm operations at once: the 3M AFFF claims administration schedule beginning its 2026 payment tranche, the December 31 window to update California lien-intake documentation ahead of SB 623, and year-end case valuation work that will now reference the Birkel punitive ratio in pain-clinic demand letters nationwide.
DuPont's roughly 13,700 pending PFAS cases remain the open variable; whether that defendant mirrors 3M's settlement structure or holds out for lower per-plaintiff numbers will shape AFFF practice group staffing decisions well into 2027.
California practitioners handling rideshare lien cases have 56 days from this wrap's publication to complete billing audits before the FAIR Health 70th-percentile cap takes effect, and no appellate guidance yet exists on how courts will calculate that benchmark when a provider's historical billing predates the statute.
No court has yet ruled on how SB 623's 70th-percentile benchmark applies to billing that predates the statute itself.